MissionIR Articles

Synergy Pharmaceuticals, Inc. (NASDAQ: SGYP) is a biopharmaceutical company focused on the development of novel therapies to treat gastrointestinal diseases and disorders. The company’s product pipeline includes two drug candidates currently being studied in four…

Solitron Devices, Inc. (OTCQB: SODI) designs, develops, manufactures and markets solid-state semiconductor components and related devices primarily for the military and aerospace markets. The majority of the company’s products are custom made pursuant to contracts…

Synergy Resources Corp. is a domestic oil and natural gas exploration and production company operating in the Wattenberg Field of the Denver-Julesburg Basin in northeast Colorado. The company operates 308 wells throughout the region, in…

Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on the development and commercialization of products to treat serious and life-threatening diseases. The company’s product pipeline includes two phase III product candidates. The first, Blisibimod, is…

Heron Therapeutics, Inc. (NASDAQ: HRTX) is a biotechnology company focused on the development and commercialization of best-in-class pharmaceutical products that address major unmet medical needs. The company’s leading drug candidate, SUSTOL®, is being developed for…

Callidus Software, Inc. (NASDAQ: CALD), doing business as CallidusCloud®, is the global leader in cloud-based sales, marketing, learning and customer experience solutions. The company’s proprietary suite of business offerings enables customers to identify leads, ensure…

Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) is a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon its expertise in novel tetracycline chemistry. The company’s leading product candidate, omadacycline, is the first…

Transfer agents may perform the same basic functions but the team at Continental Stock Transfer & Trust knows that being the agent of choice requires more. As only major transfer agent specializing in small to…

Organovo Holdings, Inc. (NYSE MKT: ONVO) is an early commercial stage company focusing on the development and commercialization of functional human tissues for use in drug discovery and medical research. Utilizing its proprietary three-dimensional bioprinting…

Cytori Therapeutics, Inc. is a biotechnology company developing autologous cell therapies from adipose connective tissue designed to treat a variety of medical conditions. Since 2001, the company has leveraged its exploration of the massive treatment…

Net Element, Inc. (NASDAQ: NETE) issued a response to shareholder inquiries on Tuesday, addressing concerns regarding the company’s recent decline in share prices and the resulting non-compliance notice received from NASDAQ. In particular, the company…

Apricus Biosciences, Inc. (NASDAQ: APRI) is a biopharmaceutical company advancing innovative medicines in urology and rheumatology. The company’s lead product, Vitaros®, is approved in Europe and Canada for the treatment of erectile dysfunction and is…

DexCom, Inc. (NASDAQ: DXCM) develops and markets continuous glucose monitoring (CGM) products and tools to help adults and pediatric patients better manage their diabetes. CGM is an FDA-approved technology that provides real-time readings throughout the…

The applications for social technology in the corporate world are moving at warp speed. Once a means of entertainment, e-mail access and online shopping, social technology has become so entrenched within global businesses, that it…

Not long ago, the thought of using your smartphone to pay for merchandise at retail shops was considered wishful thinking. It was fun to talk about but those in conversation knew the technology needed to…

Energy Focus, Inc. (NASDAQ: EFOI) is a leading provider of energy efficient LED lighting products in the United States and abroad. The company’s current customer base includes national, state and local government agencies, Fortune 500…

In its recently reported second-quarter earnings release, California-based Limoneira Co. (NASDAQ: LMNR) easily topped analyst expectations with earnings of $2.6 million, or $0.17 per share, on revenue of $28.3 million. Despite operating from the thirsty,…